Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Jordan
A single blinded prospective randomized controlled trial conducted in family medicine outpatients clinics in Jordan. The study enrolled 199 patients met the National Cholesterol Education Program Adult Treatment Panel III (NCEP/ATPIII) criteria for the diagnosis of MS upon the time of enrollment. Patients were randomized into: 110 participants into the intervention arm (pharmacist-physician collaborative approach) and 89 into the control arm (physician only team). Only patients in the intervention arm were provided pharmacist recommendations and pharmaceutical care counseling.
Age
32–88
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Meeting at least 3 of the 5 criteria for the National Cholesterol Education Program Adult Treatment Panel III (NCEP/ATPIII) for the diagnosis of Metabolic syndrome upon the time of enrollment. :
1. Abdominal circumference \>102 cm in males or \>88 cm in females.
2. HDL cholesterol \< 40 mg/dl for males or \< 50 mg/dl for females.
3. Triglycerides ≥ 150 mg/dl.
4. Blood pressure ≥ 130/85 mmHg or receiving hypertension treatment.
5. Baseline glycemia ≥ 110 mg/dl.
You may not be if
1. Patients with hypertensive urgency or emergency with BP more than (180/110).
2. Patients with recent stroke or myocardial infraction (within past 6 months).
3. Patients with Class III or IV Chronic heart Failure (CHF).
4. Patients with Unstable angina.
5. Patients with Serious renal or hepatic disease.
6. Pregnant patients.
7. Patients with Dementia or cognitive impairment.
8. If the patient is unable to provide informed written consent.